TTR and Alzheimer disease: As an evolutionarily conserved protein, TTR serves as an endogenous detoxifier to bind Aβ peptides and regulate their aggregation in a chaperone-like manner in AD transgenic mouse model [41, 42], indicating that the role of celastrol in inhibiting Aβ aggregation may also contribute to its effects in alleviating AD pathology.